Xeris Biopharma (XERS) EBITDA (2020 - 2026)
Xeris Biopharma (XERS) EBITDA from Mar 31, 2020 to Mar 31, 2026. The TTM Xeris Biopharma (XERS) EBITDA is $37M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Annual EBITDA change of Xeris Biopharma (XERS)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $8.25M | -68.52% |
| 2025 | $26M | -180.85% |
| 2024 | -$32M | -23.75% |
| 2023 | -$43M | -47.21% |
| 2022 | -$81M | -29.25% |
| 2021 | -$114M | +38.68% |
| 2020 | -$82M | N/A |